{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:35:47Z","timestamp":1790948147261,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,7]]},"abstract":"<jats:p>In this study, we aimed to explore the clinical significance of serum CK18-M65 and CK18-M30 levels in patients with chronic hepatitis B (CHB) complicated by nonalcoholic steatohepatitis (NASH) and liver fibrosis. The observation and control groups comprised 133 patients with CHB complicated by NASH and 50 healthy patients from our hospital, respectively. Liver function indices, including alanine aminotransferase, glutamic aminotransferase, \u03b3-glutamyltransferase, total bilirubin, total protein, and total cholesterol, were determined using an automatic biochemical analyzer. Hyaluronic acid, type III procollagen, type IV collagen, laminin, and CK18-M65 and M30 levels were detected using ELISA. Serum CK18-M65 and M30 levels in patients with CHB complicated by NASH were positively correlated with the liver fibrosis stage (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). While serum CK18-M65 demonstrated a low diagnostic value for liver fibrosis in the S0-1 stage, it exhibited good diagnostic value for S2-3 stage liver fibrosis. Serum CK18-M30 displayed good diagnostic value for S0-1 and S2-3 hepatic fibrosis, particularly for S2-3 hepatic fibrosis. Elevated serum CK18-M65 and CK18-M30 levels in patients with CHB complicated with NASH suggest their potential utility in evaluating the progression of liver fibrosis in this population. In particular, CK18-M30 exhibits superior diagnostic efficiency.<\/jats:p>","DOI":"10.1097\/md.0000000000038342","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T14:07:57Z","timestamp":1717769277000},"page":"e38342","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Clinical significance of serum Ck18-M65 and M30 levels in patients with chronic hepatitis B combined with nonalcoholic steatohepatitis and liver fibrosis"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6707-3935","authenticated-orcid":false,"given":"Lu","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Shenzhen Hospital, Peking University, Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Shenzhen Hospital, Peking University, Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Shenzhen Hospital, Peking University, Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1056\/NEJMoa2210027","article-title":"Efficacy and safety of bepirovirsen in chronic hepatitis B infection.","volume":"387","author":"Yuen","year":"2022","journal-title":"N Engl J Med"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/liv.14369","article-title":"Chronic hepatitis B and non-alcoholic fatty liver disease: conspirators or competitors?","volume":"40","author":"Zhang","year":"2020","journal-title":"Liver Int"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/liv.15252","article-title":"Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.","volume":"42","author":"Yang","year":"2022","journal-title":"Liver Int"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.3748\/wjg.v21.i41.11567","article-title":"Non-invasive diagnosis of liver fibrosis and cirrhosis.","volume":"21","author":"Lurie","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-9255-10-37","article-title":"Expression of AIM2 is high and correlated with inflammation in hepatitis B virus associated glomerulonephritis.","volume":"10","author":"Du","year":"2013","journal-title":"J Inflamm (Lond)"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jhep.2018.11.025","article-title":"Non-invasive diagnosis and biomarkers in alcohol-related liver disease.","volume":"70","author":"Moreno","year":"2019","journal-title":"J Hepatol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1023\/A:1005556328028","article-title":"Correlation between stellate cell activation and serum fibrosis markers in choline-deficient L-amino acid-defined diet-induced rat liver fibrosis.","volume":"45","author":"Hironaka","year":"2000","journal-title":"Dig Dis Sci"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00508-007-0921-1","article-title":"Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?","volume":"120","author":"Kazemi-Shirazi","year":"2008","journal-title":"Wien Klin Wochenschr"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/gut.2007.123943","article-title":"Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.","volume":"57","author":"Papatheodoridis","year":"2008","journal-title":"Gut"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcv.2013.10.008","article-title":"Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection.","volume":"58","author":"Bae","year":"2013","journal-title":"J Clin Virol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"6430486","DOI":"10.1155\/2019\/6430486","article-title":"Management of diabetes mellitus in patients with chronic liver diseases.","volume":"2019","author":"Zhao","year":"2019","journal-title":"J Diabetes Res"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jhep.2017.05.021","article-title":"CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.","volume":"67","author":"Savio","year":"2017","journal-title":"J Hepatol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.27841","article-title":"Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury.","volume":"62","author":"Huang","year":"2015","journal-title":"Hepatology"},{"issue":"12 Suppl","key":"R15-20250503","first-page":"S33","article-title":"Therapeutic strategies for chronic hepatitis B virus infection in 2008.","volume":"121","author":"Khokhar","year":"2008","journal-title":"Am J Med"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"7603410","DOI":"10.1155\/2020\/7603410","article-title":"Clinical efficacy and safety of eight traditional Chinese medicine combined with entecavir in the treatment of chronic hepatitis B liver fibrosis in adults: a network meta-analysis.","volume":"2020","author":"Wang","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5603\/FHC.a2022.0011","article-title":"Extracts of Periplaneta Americana alleviate hepatic fibrosis by affecting hepatic TGF-\u03b2 and NF-\u03baB expression in rats with pig serum-induced liver fibrosis.","volume":"60","author":"Li","year":"2022","journal-title":"Folia Histochem Cytobiol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/ar.23567","article-title":"Basement membrane type IV collagen and laminin: an overview of their biology and value as fibrosis biomarkers of liver disease.","volume":"300","author":"Mak","year":"2017","journal-title":"Anat Rec (Hoboken)"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3348\/kjr.2016.17.3.396","article-title":"Liver shear-wave velocity and serum fibrosis markers to diagnose hepatic fibrosis in patients with chronic viral hepatitis B.","volume":"17","author":"Liu","year":"2016","journal-title":"Korean J Radiol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3748\/wjg.v26.i1.86","article-title":"Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors.","volume":"26","author":"Franck","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcmgh.2017.11.016","article-title":"Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-Related Factor 2).","volume":"5","author":"Sharma","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/CEG.S135526","article-title":"Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B.","volume":"10","author":"Li","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"issue":"Pt 7","key":"R23-20250503","first-page":"1464","article-title":"Mutation of caspase-digestion sites in keratin 18 interferes with filament reorganization, and predisposes to hepatocyte necrosis and loss of membrane integrity.","volume":"127","author":"Weerasinghe","year":"2014","journal-title":"J Cell Sci"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"e10106","DOI":"10.5812\/hepatmon.10106","article-title":"The clinical significance of serum apoptotic cytokeratin 18 neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) levels in chronic hepatitis B patients with cirrhosis.","volume":"13","author":"Sumer","year":"2013","journal-title":"Hepat Mon"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.24734","article-title":"Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis.","volume":"55","author":"Joka","year":"2012","journal-title":"Hepatology"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.dld.2015.09.008","article-title":"Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis.","volume":"48","author":"Rosso","year":"2016","journal-title":"Dig Liver Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:26:02Z","timestamp":1746318362000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":26,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038342","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}